Formidable Asset Management’s AEON Biopharma AEON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,572
| Closed | -$372K | – | 385 |
|
|
2024
Q4 | $372K | Buy |
9,572
+4,158
| +77% | +$162K | 0.06% | 270 |
|
|
2024
Q3 | $409K | Buy |
5,414
+3,836
| +243% | +$290K | 0.07% | 251 |
|
|
2024
Q2 | $119K | Buy |
1,578
+631
| +67% | +$47.7K | 0.02% | 379 |
|
|
2024
Q1 | $791K | Buy |
947
+139
| +17% | +$116K | 0.13% | 163 |
|
|
2023
Q4 | $419K | Sell |
808
-85
| -10% | -$44.1K | 0.09% | 190 |
|
|
2023
Q3 | $360K | Buy |
+893
| New | +$360K | 0.08% | 207 |
|